Ronald Pauli

Ronald Pauli is a declared insider at 3 companies; the most frequent names are Horizon Therapeutics Public Ltd Co, Neopharm Inc and Sagent Pharmaceuticals, Inc. The record holds 10 filings, for trades running from 5 October 2006 to 2 May 2019.

Every open-market trade on record is a purchase: 1 purchase worth €8,886, and no sale. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. The rest of the record consists of 5 share grants and 4 option exercises.

Most recently, on 6 May 2019, the filings show a share grant worth €140k in Horizon Therapeutics Public Ltd Co. The clock since the last published purchase (6 October 2006) now reads 7,339 days. Typically, a trade is published a median of 4 days after it takes place. For comparison, the SEC allows two business days to file a Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.